PHOENIX was featured in the latest BNN QUARTERLY issue (Dec 2022) with an article about “Characterization of Nanomedicines to Ensure Pharmaceutical Quality, Speeding their Translation to the Clinics” by our partner Nanomol Technologies (pages 26-28).
Enjoy reading!